Phibro Animal Health Corporation PAHC
Set alert
As of Nov 3, 10:27 AM ET
- YTD
- +4.27%
- 1 year
- -10.18%
- Open
- 38.93
- Prev close
- 38.74
- Mkt cap
- 1.58B
- Vol
- 11.69K
- Avg vol
- 219.17K
- EPS
- 2.43
- P/E
- 16.04
- Div yield
- 1.24%
More statistics
- Low
- 38.40
- High
- 39.53
- Forward P/E
- 10.07
- Beta
- 0.40
- Short ratio
- 4.10
- Inst. own
- 102.94%
- Dividend
- 0.48
- Ex-div date
- Sep 1, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 36.99
- 200-d avg
- 41.26
- 1y target
- 47.00
News
5 days ago businesswire.com
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 4, 2026, after the market closes. Phibro…
2 months ago benzinga.com
Phibro Animal Health Q4 2026 Earnings Call: Complete Transcript
Phibro Animal Health (NASDAQ:PAHC) held its fourth-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs.…
-
2 months ago benzinga.com
Phibro Animal Health Corp To Close Chicago Heights Facility In Summer 2027, Affecting About 100 Employees
MFA SITE CLOSUREThrough the MFA acquisition in 2024, Phibro added several manufacturing facilities. Since then, we have conducted a comprehensive review of our manufacturing network to ensure our…
-
2 months ago benzinga.com
Phibro Animal Health Sees FY2027 Adj EPS $3.41-$3.59 vs $3.34 Est; Sees Sales $1.550B-$1.600B vs $1.548B Est
Phibro Animal Health (NASDAQ:PAHC) is looking for FY2027 Adj EPS of $3.41-$3.59 vs $3.34 analyst estimate. sees sales of $1.550 billion-$1.600 billion vs $1.548 billion analyst estimate.
-
4 months ago benzinga.com
Phibro Animal Health Appoints Daniel (Dani) Bendheim As CEO And President Effective July 1, 2026
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001069899/000110465926078323/tm2619111d1_8k.htm
-
5 months ago benzinga.com
Citigroup Maintains Neutral on Phibro Animal Health, Lowers Price Target to $44
Citigroup analyst Daniel Grosslight maintains Phibro Animal Health (NASDAQ:PAHC) with a Neutral and lowers the price target from $62 to $44.
-
6 months ago benzinga.com
Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.93-$3.10 to $2.98-$3.10 vs $3.03 Est; Raises FY2026 Sales Guidance from $1.45B-$1.50B to $1.46B-$1.50B vs $1.488B Est
FISCAL YEAR 2026 FINANCIAL GUIDANCEOur updated fiscal year 2026 financial guidance is as shown below. Year-over-year percentages are calculated using the midpoint of the guidance ranges.Net sales of…
-
6 months ago benzinga.com
Phibro Animal Health Corporation Announces Expected Implementation Of New Regulatory Framework Governing The Use Of Certain Antimicrobials In Brazil
The Brazilian Ministry of Agriculture and Livestock (MAPA) published Ordinance No. 1617 on April 27, 2026, prohibiting the importation, manufacture, marketing and use of performance enhancing feed…
-
6 months ago benzinga.com
Citigroup Initiates Coverage On Phibro Animal Health with Neutral Rating, Announces Price Target of $62
Citigroup analyst Daniel Grosslight initiates coverage on Phibro Animal Health (NASDAQ:PAHC) with a Neutral rating and announces Price Target of $62.
9 months ago benzinga.com
Hershey Posts Upbeat Q4 Earnings, Joins FormFactor, ITT, Cardinal Health And Other Big Stocks Moving Higher On Thursday
Hershey Posts Upbeat Q4 Earnings, Joins FormFactor, ITT, Cardinal Health And Other Big Stocks Moving Higher On Thursday
9 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
9 months ago benzinga.com
Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
-
9 months ago benzinga.com
Phibro Animal Health Raises FY2026 GAAP EPS Guidance from $1.83-$2.08 to $2.08-$2.32 vs $1.99 Est
Phibro Animal Health (NASDAQ:PAHC) raises FY2026 GAAP EPS guidance from $1.83-$2.08 to $2.08-$2.32 vs $1.99 analyst estimate..
-
9 months ago benzinga.com
Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.64-$2.81 to $2.93-$3.10 vs $2.74 Est; Raises FY2026 Sales Guidance from $1.430B-$1.480B to $1.450B-$1.500B vs $1.466B Est
Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.64-$2.81 to $2.93-$3.10 vs $2.74 analyst estimate. Raises FY2026 sales outlook from $1.430 billion-$1.480 billion to $1.450…
9 months ago benzinga.com
Phibro Animal Health Earnings Review: Q2 Summary
Phibro Animal Health Earnings Review: Q2 Summary
-
9 months ago benzinga.com
Phibro Animal Health Q2 Adj. EPS $0.87 Beats $0.67 Estimate, Sales $373.900M Beat $355.637M Estimate
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.67 by 29.85 percent. This is a 58.18 percent increase over earnings…
-
9 months ago benzinga.com
Earnings Scheduled For February 4, 2026
Earnings Scheduled For February 4, 2026
9 months ago benzinga.com
Earnings Preview For Phibro Animal Health
Earnings Preview For Phibro Animal Health
-
12 months ago benzinga.com
JP Morgan Maintains Overweight on Phibro Animal Health, Raises Price Target to $50
JP Morgan analyst Ekaterina Knyazkova maintains Phibro Animal Health (NASDAQ:PAHC) with a Overweight and raises the price target from $45 to $50.
-
12 months ago benzinga.com
Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.52-$2.70 to $2.64-$2.81 vs $2.63 Est; Affirms FY2026 Sales Guidance of $1.430B-$1.480B vs $1.459B Est
Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.52-$2.70 to $2.64-$2.81 vs $2.63 analyst estimate. Affirms FY2026 sales outlook from $1.430 billion-$1.480 billion to $1.430…
-
12 months ago benzinga.com
Phibro Animal Health Q1 Adj. EPS $0.73 Beats $0.62 Estimate, Sales $363.900M Beat $346.957M Estimate
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.62 by 17.17 percent. This is a 108.57 percent increase over earnings…
12 months ago benzinga.com
Earnings Scheduled For November 5, 2025
Earnings Scheduled For November 5, 2025
-
12 months ago benzinga.com
A Preview Of Phibro Animal Health's Earnings
A Preview Of Phibro Animal Health's Earnings
-
1 year ago benzinga.com
Phibro Animal Health To Develop, Commercialize Lighthouse Pharma's Proprietary Compound For Canine Periodontal Care Under Signed Licensing Agreement
TEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ:PAHC), a global leader in animal health and nutrition, today announced it has entered into a licensing agreement with…
-
1 year ago benzinga.com
B of A Securities Maintains Underperform on Phibro Animal Health, Raises Price Target to $27
B of A Securities analyst Derik De Bruin maintains Phibro Animal Health (NASDAQ:PAHC) with a Underperform and raises the price target from $19 to $27.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
1 year ago benzinga.com
Phibro Animal Health, Pure Storage, Snowflake, Build-A-Bear Workshop And Other Big Stocks Moving Higher On Thursday
Phibro Animal Health, Pure Storage, Snowflake, Build-A-Bear Workshop And Other Big Stocks Moving Higher On Thursday
1 year ago benzinga.com
Stock Market Today: Nvidia Drags Down Nasdaq Futures, Dow Trades Higher—Dollar General, Dell, Best Buy In Focus (UPDATED)
U.S. stock futures were swinging on Thursday following Wednesday's advances. Futures of major benchmark indices were largely mixed.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
1 year ago benzinga.com
Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
1 year ago benzinga.com
Phibro Animal Health Stock Surges 18% After-Hours On Strong Q4 Earnings Beat
Phibro shares soared nearly 18% after strong Q4 results beat estimates, driven by growth from the Zoetis MFA acquisition and solid full-year performance.
-
1 year ago benzinga.com
Phibro Animal Health Sees FY2026 Adj EPS $2.52-$2.70 vs $2.03 Est; Sees Sales $1.430B-$1.480B vs $1.278B Est
Phibro Animal Health (NASDAQ:PAHC) is looking for FY2026 Adj EPS of $2.52-$2.70 vs $2.03 analyst estimate. sees sales of $1.430 billion-$1.480 billion vs $1.278 billion analyst estimate.
-
1 year ago benzinga.com
Phibro Animal Health Q4 EPS $0.57 Beats $0.52 Estimate, Sales $378.70M Beat $361.80M Estimate
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.52 by 9.62 percent. This is a 39.02 percent increase over earnings of…
-
1 year ago benzinga.com
Earnings Scheduled For August 27, 2025
Earnings Scheduled For August 27, 2025
-
1 year ago benzinga.com
A Look Ahead: Phibro Animal Health's Earnings Forecast
A Look Ahead: Phibro Animal Health's Earnings Forecast
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
1 year ago benzinga.com
Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost
Phibro Animal Health gains JPMorgan upgrade as analyst forecasts continued growth across key livestock products and long-term fundamentals.
1 year ago benzinga.com
U.S. Bancorp To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
U.S. Bancorp To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
1 year ago benzinga.com
Top 2 Health Care Stocks That May Plunge This Month
Top 2 Health Care Stocks That May Plunge This Month
1 year ago benzinga.com
This Constellation Brands Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday
This Constellation Brands Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday
-
1 year ago benzinga.com
JP Morgan Upgrades Phibro Animal Health to Overweight, Raises Price Target to $35
JP Morgan analyst Ekaterina Knyazkova upgrades Phibro Animal Health (NASDAQ:PAHC) from Neutral to Overweight and raises the price target from $25 to $35.
-
1 year ago benzinga.com
Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Raises Price Target to $26
Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and raises the price target from $21 to $26.
-
1 year ago benzinga.com
Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Raises Price Target to $21
Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and raises the price target from $20 to $21.
-
1 year ago benzinga.com
Phibro Animal Health Raises FY2025 GAAP EPS Guidance from $0.96-$1.11 to $0.98-$1.11 vs $1.27 Est
Phibro Animal Health (NASDAQ:PAHC) raises FY2025 GAAP EPS guidance from $0.96-$1.11 to $0.98-$1.11 vs $1.27 analyst estimate..
-
1 year ago benzinga.com
Phibro Animal Health Raises FY2025 Adj EPS Guidance from $1.87-$2.01 to $1.96-$2.09 vs $1.94 Est; Narrows FY2025 Sales Guidance from $1.25B-$1.30B to $1.26B-$1.29B vs $1.28B Est
Phibro Animal Health (NASDAQ:PAHC) raises FY2025 Adj EPS guidance from $1.87-$2.01 to $1.96-$2.09 vs $1.94 analyst estimate. Narrows FY2025 sales outlook from $1.25 billion-$1.30 billion to $1.26…
-
1 year ago benzinga.com
Phibro Animal Health Q3 Adj. EPS $0.63 Beats $0.52 Estimate, Sales $347.80M Miss $352.40M Estimate
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.52 by 21.15 percent. This is a 103.23 percent increase over earnings…
-
1 year ago benzinga.com
Barclays Maintains Underweight on Phibro Animal Health, Raises Price Target to $22
Barclays analyst Balaji Prasad maintains Phibro Animal Health (NASDAQ:PAHC) with a Underweight and raises the price target from $20 to $22.
-
1 year ago benzinga.com
Phibro Animal Health Raises FY2025 Adj EPS Guidance from $1.34-1.48 to $1.87-2.01 vs $1.64 Est; Raises FY2025 Sales Guidance from $1.05B-1.10B to $1.25B-1.30B vs $1.27B Est
Phibro Animal Health (NASDAQ:PAHC) raises FY2025 Adj EPS guidance from $1.34-1.48 to $1.87-2.01 vs $1.64 analyst estimate. Raises FY2025 sales outlook from $1.05 billion-1.10 billion to $1.25…